Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1
Journal of Clinical Investigation · 15.06.2026 · 136 (12)
DOI: 10.1172/jci195723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 07.05.2026. Verfasst von Changwoo Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Neuroscience Program and. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Purkinje Cells, Oligodendroglia, Axons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease marked by progressive motor deficits and Purkinje cell (PC) degeneration, driven by polyglutamine expansion in ataxin-1. While oligodendroglial dysfunction precedes PC loss, its direct contribution toward SCA1 pathogenesis remains unclear. Here, using an oligodendroglia-specific SCA1 conditional knockin mouse model, we demonstrate that mutant ataxin-1 in oligodendrocytes is sufficient to drive aspects of SCA1-related pathology, including dysregulated myelination, PC axonal shrinkage, and torpedo formation, ultimately impairing motor coordination. Transcriptomic analysis uncovers cerebellar oligodendrocyte subtypes with distinct gene expression signatures and aberrant abundance that contribute to demyelination. This, compounded by a progressive decline in the neuroprotective functions of a cerebellum-specific oligodendrocyte subtype, establishes a critical link between demyelination, axo-myelinic dysfunction, and axonal pathology in SCA1. Upstream transcriptional regulator analysis in oligodendroglia identifies transcription factor 7-like 2 (TCF7L2) and huntingtin (HTT) as key mediators of oligodendroglial dysfunction in SCA1, suggesting shared pathogenic mechanisms with other polyglutamine diseases. Collectively, these findings establish oligodendroglia as key mediators of SCA1 pathogenesis and underscore their critical role in preserving PC axonal integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdepartmental Neuroscience Program and.
- Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
- Yale College, New Haven, Connecticut, USA.
- Departments of Neurology and Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
- Department of Neuroscience.
- Program in Cellular Neuroscience, Neurodegeneration and Repair.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Ataxia Foundation
- Wu Tsai Institute, Yale University
- National Institute of General Medical Sciences
Zitieren
APA
Lee, C., Grijalva, R. M., Tejwani, L., Bae, E., Chase, A., Ro, H., Kim, H., Olmos, V., Orengo, J. P., & Lim, J. (2026). Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1. Journal of Clinical Investigation, 136(12). https://doi.org/10.1172/jci195723
Vancouver
Lee C, Grijalva RM, Tejwani L, Bae E, Chase A, Ro H, et al. Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1. Journal of Clinical Investigation. 2026;136(12). doi:10.1172/jci195723
BibTeX
@article{Lee2026,
author = {Lee, Changwoo and Grijalva, Rosalie M and Tejwani, Leon and Bae, Eunwoo and Chase, Alison and Ro, Hannah and Kim, Hannah and Olmos, Victor and Orengo, James P and Lim, Janghoo},
title = {Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {12},
doi = {10.1172/jci195723}
}
EUVIMED